The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| BIEI | -12.5% | -73.08% | -23.06% | -100% |
| S&P | +13.95% | +78.35% | +12.25% | +394% |
Premier Biomedical, Inc. is a research-based company, which engages in the development and discovery of medical products. It focuses on the development and distribution of hemp oil based topical pain relief products. The company was founded by Mitchell S. Felder on May 10, 2010 and is headquartered in Southfield, MI.
No news articles found for Premier Biomedical.
| Q1 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00K | 0.0% |
| Gross Profit | $0.00K | 0.0% |
| Market Cap | $490.00K | -51.0% |
| Net Income | -$12.39K | 28.6% |
| EBITDA | -$12.38K | 28.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q1 2025 | YOY Change | |
|---|---|---|
| Net Cash | $0.41K | 0.0% |
| Inventory | 0 | 0.0% |
| Q1 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00K | 0.0% |
| Short Term Debt | $703.20K | 23.7% |
| Q1 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -2810.96% | 860.7% |
| Return On Invested Capital | 7.56% | -2.6% |
| Q1 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$9.88K | 71.5% |
| Operating Free Cash Flow | -$9.89K | 71.5% |
| Metric | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -0.35 | -0.44 | -0.28 | -0.21 | -52.47% |
| Price to Tangible Book Value | -0.35 | -0.44 | -0.28 | -0.21 | -52.54% |
| Enterprise Value to EBITDA | -133.60 | -95.60 | -118.95 | -104.39 | 8.43% |
| Total Debt | $568.34K | $627.43K | $607.56K | $703.20K | 23.73% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
